Alternate replication in B cells and epithelial cells switches tropism of Epstein–Barr virus

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Nature Medicine

• Publication date

  2002-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nm0602-594PMID 12042810
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epstein-Barr Virus Entry Utilizing HLA-DP or HLA-DQ as a Coreceptor

  2000cited by this paper
• Coreceptor restriction within the HLA-DQ locus for Epstein-Barr virus infection.

  2000cited by this paper
• Cellular expression of alphaherpesvirus gD interferes with entry of homologous and heterologous alphaherpesviruses by blocking access to a shared gD receptor.

  2000cited by this paper
• Three classes of cell surface receptors for alphaherpesvirus entry.

  2000cited by this paper
• Epstein-Barr Virus gH Is Essential for Penetration of B Cells but Also Plays a Role in Attachment of Virus to Epithelial Cells

  2000cited by this paper
• Epstein-Barr Virus Lacking Glycoprotein gp42 Can Bind to B Cells but Is Not Able To Infect

  1998cited by this paper
• Epstein-Barr Virus Recombinant Lacking Expression of Glycoprotein gp150 Infects B Cells Normally but Is Enhanced for Infection of Epithelial Cells

  1998cited by this paper
• Direct Visualization of Antigen-specific CD8+T Cells during the Primary Immune Response to Epstein-Barr Virus In Vivo

  1998cited by this paper
• Epstein-Barr Virus Uses Different Complexes of Glycoproteins gH and gL To Infect B Lymphocytes and Epithelial Cells

  1998cited by this paper
• An animal model for acute and persistent Epstein-Barr virus infection.

  1997cited by this paper
• Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes

  1997cited by this paper
• The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells

  1995cited by this paper
• Lonely MHC molecules seeking immunogenic peptides for meaningful relationships.

  1995cited by this paper
• Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes

  1994cited by this paper
• Epstein-Barr virus glycoprotein gp85 associates with the BKRF2 gene product and is incompletely processed as a recombinant protein.

  1993cited by this paper
• Epstein–Barr virus infection and replication in a human epithelial cell system

  1992cited by this paper
• Epstein-Barr virus.

  1991cited by this paper
• Depletion of glycoprotein gp85 from virosomes made with Epstein-Barr virus proteins abolishes their ability to fuse with virus receptor-bearing cells

  1989cited by this paper
• A monoclonal antibody to glycoprotein gp85 inhibits fusion but not attachment of Epstein-Barr virus

  1988cited by this paper
• Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d

  1987cited by this paper
• Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis.

  1987cited by this paper
• Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2)

  1985cited by this paper
• Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis.

  1984cited by this paper
• Cross‐linking of cell surface immunoglobulins induces epstein‐barr virus in burkitt lymphoma lines

  1984cited by this paper
• Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.

  1984cited by this paper
• Specific antimononuclear phagocyte monoclonal antibodies. Application to the purification of dendritic cells and the tissue localization of macrophages

  1983cited by this paper

• Infectious Mononucleosis.

  2025cites this paper
• Epstein–Barr virus pathogenesis and emerging control strategies

  2025cites this paper
• A Bivalent mRNA Vaccine Efficiently Prevents Gammaherpesvirus Latent Infection

  2025cites this paper
• Identified receptors shed light on Epstein–Barr virus infection

  2025cites this paper
• Epstein-Barr virus+ inflammatory follicular dendritic cell sarcoma with clonal immunoglobulin heavy chain gene rearrangement: A case report and literature review

  2025cites this paper
• COVID-19, Epstein-Barr virus reactivation and autoimmunity: Casual or causal liaisons?

  2025cites this paper
• Epstein–Barr virus BALF0/1 subverts the Caveolin and ERAD pathways to target B cell receptor complexes for degradation

  2025cites this paper
• R9AP is a common receptor for EBV infection in epithelial cells and B cells

  2025cites this paper
• Vitamin D Imbalance and Hydro-Electrolyte Disturbances in Hospitalized Children: A Comparation Between Post-COVID-19 Status and SARS-CoV-2/EBV Coinfection

  2025cites this paper
• Recent Progress in the Vaccine Development Against Epstein–Barr Virus

  2025cites this paper
• Relationship between Epstein-Barr virus and inflammatory bowel disease

  2025cites this paper
• Anti-Epstein–Barr Virus Activities of Flavones and Flavonols with Effects on Virus-Related Cancers

  2025cites this paper
• In Silico Redesign of Epstein-Barr Virus Entry Glycoproteins to Redirect Cellular Tropism as a Foundation for a Novel B Cell Oncolytic Therapy

  2025cites this paper
• The hidden impact of producer cells on virion composition and infectivity.

  2025cites this paper
• Animal models of human herpesvirus infection

  2025cites this paper
• The producer cell type of HSV-1 alters the proteomic contents and infectious capacity of virions

  2025influential citation
• Oncoviruses in the Oral Cavity: Recent Advances in Understanding Viral Infections and Tumorigenesis

  2025cites this paper
• The producer cell type of HSV-1 alters the proteomic contents and infectious capacity of virions

  2025cites this paper
• Viral Entry.

  2025cites this paper
• High IgG titers against EBV glycoprotein 42 correlate with lower risk of nasopharyngeal carcinoma

  2025cites this paper
• Targeting EBV gp42 for nasopharyngeal carcinoma prevention.

  2025cites this paper
• Innate Immune Recognition of EBV.

  2025cites this paper
• Epstein-Barr Virus (EBV)-Specific Humoral Immune Responses in Health and Disease.

  2025cites this paper
• The role of cytokines from salivary gland epithelial cells in the immunopathology of Sjögren’s syndrome

  2024cites this paper
• A large-scale population-based study reveals that gp42-IgG antibody is protective against EBV–associated nasopharyngeal carcinoma

  2024cites this paper
• Update on human herpesvirus 7 pathogenesis and clinical aspects as a roadmap for future research

  2024cites this paper
• Host genetic variants, Epstein-Barr virus subtypes, and the risk of nasopharyngeal carcinoma: Assessment of interaction and mediation

  2024cites this paper
• Chronic HIV‐1 Tat action induces HLA‐DR downregulation in B cells: A mechanism for lymphoma immune escape in people living with HIV

  2024cites this paper
• Epstein-Barr virus-encoded Latent Membrane protein-1(LMP-1) as a Prognostic marker in OSCC and OPMDs

  2024cites this paper
• Potent human monoclonal antibodies targeting Epstein-Barr virus gp42 reveal vulnerable sites for virus infection

  2024cites this paper
• Research landmarks on the 60th anniversary of Epstein-Barr virus

  2024cites this paper
• A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection

  2024cites this paper
• Epstein-Barr virus gp42 antibodies reveal sites of vulnerability for receptor binding and fusion to B cells.

  2024cites this paper
• Epigenetic reprograming in myalgic encephalomyelitis/chronic fatigue syndrome: A narrative of latent viruses

  2024cites this paper
• Fibroblast, Epithelial and Endothelial Cell-Derived Human Cytomegalovirus Strains Display Distinct Neutralizing Antibody Responses and Varying Levels of gH/gL Complexes

  2023cites this paper
• Antibodies Against Epstein–Barr Virus as Disease Markers of Gastric Cancer: A Systematic Review

  2023cites this paper
• T cell-mediated immunity during Epstein-Barr virus infections in children.

  2023cites this paper
• Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID

  2023cites this paper
• Incidence and association of high-risk HPVs and EBV in patients with advanced stages of colorectal cancer from Qatar

  2023cites this paper
• Neutralizing antibodies against EBV gp42 show potent in vivo protection and define novel epitopes

  2023cites this paper
• Wildebeest-Derived Malignant Catarrhal Fever: A Bovine Peripheral T Cell Lymphoma Caused by Cross-Species Transmission of Alcelaphine Gammaherpesvirus 1

  2023cites this paper
• Relationship of human cytomegalovirus‐infected endothelial cells and circulating leukocytes in the pathogenesis of disseminated human cytomegalovirus infection: A narrative review

  2023cites this paper
• New insight into Epstein-Barr virus infection using models of stratified epithelium

  2023influential citation
• The Impact of Co-Infections for Human Gammaherpesvirus Infection and Associated Pathologies

  2023cites this paper
• Contribution of the Epstein-Barr virus to the oncogenesis of mature T-cell lymphoproliferative neoplasms

  2023cites this paper
• E3 Ubiquitin Ligases in Gammaherpesviruses and HIV: A Review of Virus Adaptation and Exploitation

  2023cites this paper
• The Epstein-Barr Virus Glycoprotein BDLF2 Is Essential for Efficient Viral Spread in Stratified Epithelium

  2023cites this paper
• Changes in SUMO-modified proteins in Epstein-Barr virus infection identifies reciprocal regulation of TRIM24/28/33 complexes and the lytic switch BZLF1

  2023cites this paper
• [Epstein-Barr virus (Herpesviridae: Lymphocryptovirus) types 1 and 2 and other viral markers in patients with nasopharyngeal carcinoma in two geographically and ethnically distinct regions of Russia].

  2023cites this paper
• The role of virus infections in Sjögren’s syndrome

  2022cites this paper
• G1/S Cell Cycle Induction by Epstein-Barr Virus BORF2 Is Mediated by P53 and APOBEC3B

  2022cites this paper
• Aspects of Biological Replication and Evolution Independent of the Central Dogma: Insights from Protein-Free Vesicular Transformations and Protein-Mediated Membrane Remodeling

  2022cites this paper
• Peripheral Blood B-Lymphocytes Are Involved in Lymphocystis Disease Virus Infection in Flounder (Paralichthys olivaceus) via Cellular Receptor-Mediated Mechanism

  2022cites this paper
• EBV Association with Lymphomas and Carcinomas in the Oral Compartment

  2022cites this paper
• Epstein-Barr virus: Biology and clinical disease.

  2022cites this paper
• A brief overview of the Epstein Barr virus and its association with Burkitt's lymphoma

  2022cites this paper
• How EBV Infects: The Tropism and Underlying Molecular Mechanism for Viral Infection

  2022influential citation
• Natural killer cell responses to human oncogenic γ-herpesvirus infections.

  2022cites this paper
• A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus

  2022cites this paper
• iTIME.219: An Immortalized KSHV Infected Endothelial Cell Line Inducible by a KSHV-Specific Stimulus to Transition From Latency to Lytic Replication and Infectious Virus Release

  2021cites this paper
• Viruses, cancer and non-self recognition

  2021cites this paper
• The Role of NK Cells in EBV Infection and EBV-Associated NPC

  2021cites this paper
• Quo vadis? Central Rules of Pathogen and Disease Tropism

  2021cites this paper
• Traditional Chinese medicine is a useful and promising alternative strategy for treatment of Sjogren's syndrome: A review.

  2021cites this paper
• Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus

  2021cites this paper
• Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells

  2021cites this paper
• Host–virus interaction and viral evasion

  2021cites this paper
• Epstein-Barr Virus miR-BART1-3p Regulates the miR-17-92 Cluster by Targeting E2F3

  2021cites this paper
• Microbiome in human cancers

  2021cites this paper
• The genomic architecture of EBV and infected gastric tissue from precursor lesions to carcinoma

  2021cites this paper
• ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells

  2021cites this paper
• The human oral virome: Shedding light on the dark matter

  2021cites this paper
• Gastric epithelial attachment of Helicobacter pylori induces EphA2 and NMHC‐IIA receptors for Epstein‐Barr virus

  2021cites this paper
• Antibody Generation and Immunogenicity Analysis of EBV gp42 N-Terminal Region

  2021cites this paper
• A comprehensive risk score for effective risk stratification and screening of nasopharyngeal carcinoma

  2021cites this paper
• Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells

  2021cites this paper
• EBV downregulates the m6A "writer" WTAP in EBV-associated gastric carcinoma.

  2021cites this paper
• The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development

  2021cites this paper
• Regulation of the Macroautophagic Machinery, Cellular Differentiation, and Immune Responses by Human Oncogenic γ-Herpesviruses

  2021cites this paper
• Immune Escape by Non-coding RNAs of the Epstein Barr Virus

  2021cites this paper
• Extranodal NK/T-Cell Lymphoma, Nasal Type: Genetic, Biologic, and Clinical Aspects with a Central Focus on Epstein–Barr Virus Relation

  2021cites this paper
• Detection of Epstein-Barr virus in gastric adenocarcinoma: qPCR and FISH comparison

  2021cites this paper
• Sjögren’s Syndrome and Viral Infections

  2021cites this paper
• Brief Introduction of Epstein-Barr Virus and Lymphoma

  2021cites this paper
• Molecular basis of EphA2 recognition by gHgL from gammaherpesviruses

  2020cites this paper
• Temporal In Vitro Raman Spectroscopy for Monitoring Replication Kinetics of Epstein–Barr Virus Infection in Glial Cells

  2020cites this paper
• An Update of the Virion Proteome of Kaposi Sarcoma-Associated Herpesvirus

  2020cites this paper
• Single-Virus Force Spectroscopy Discriminates the Intrinsic Role of Two Viral Glycoproteins upon Cell Surface Attachment.

  2020cites this paper
• Reactivation of Epstein-Barr Virus by HIF-1α Requires p53

  2020cites this paper
• Human Papillomaviruses and Epstein–Barr Virus Interactions in Colorectal Cancer: A Brief Review

  2020cites this paper
• Characterization and Establishment of a Novel EBV Strain Simultaneously Associated With Nasopharyngeal Carcinoma and B-Cell Lymphoma

  2020cites this paper
• Alcelaphine herpesvirus 1 genes A7 and A8 regulate viral spread and are essential for malignant catarrhal fever

  2020cites this paper
• mSphere of Influence: 3-D Culture Models Influence Studies on Epstein-Barr Virus Molecular Pathogenesis in the Epithelium

  2020cites this paper
• Navigating the Cytoplasm: Delivery of the Alphaherpesvirus Genome to the Nucleus.

  2020cites this paper
• Prevalence of Epstein–Barr virus (EBV) in Iranian Breast Carcinoma Patients

  2020cites this paper
• Herpesvirus and inflammatory bowel disease

  2020cites this paper
• Epstein–Barr Virus Infection of Pseudostratified Nasopharyngeal Epithelium Disrupts Epithelial Integrity

  2020cites this paper
• HLA-DPB1 and Epstein-Barr virus gp42 protein jointly contribute to the development of Hodgkin lymphoma

  2020cites this paper
• EBV miR-BART10-3p Promotes Cell Proliferation and Migration by Targeting DKK1

  2019cites this paper
• Unravelling the first key steps in equine herpesvirus type 5 (EHV5) pathogenesis using ex vivo and in vitro equine models

  2019cites this paper